Journal ArticleOPEN ACCESS

Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections: How Long Is Long Enough?

Clinical Infectious Diseases (2019) 69(11) 2011-2014
DOI: 10.1093/cid/ciz223
76Citations
Citations of this article
127Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In a multicenter, observational, propensity-score-weighted cohort of 249 adults with uncomplicated Pseudomonas aeruginosa bacteremia, patients receiving short-course (median, 9 days; interquartile range [IQR], 8-10) therapy had a similar odds of recurrent infection or death within 30 days as those receiving longer courses (median, 16 days; IQR, 14-17).

Author supplied keywords

Cite

CITATION STYLE

APA

Fabre, V., Amoah, J., Cosgrove, S. E., & Tamma, P. D. (2019). Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections: How Long Is Long Enough? Clinical Infectious Diseases, 69(11), 2011–2014. https://doi.org/10.1093/cid/ciz223

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free